Note: Ingredients listed on restricted chemical lists
EC/CAS
119-36-8
Name of the chemical
Methyl salicylate
Concentration
16.5
EC/CAS
89-78-1
Name of the chemical
Menthol; dl-menthol; l-menthol; d-menthol (40)
Concentration
3.3
EC/CAS
128-37-0
Name of the chemical
2,6-di-tert-butyl-p-cresol
Concentration
0.1
General Information
Revision date
2022-03-09
Product name
IODEX HERBAL GEL (MFC70131)
Product Synonyms
PROJECT IODEX HERBAL GEL * MFC70131 (MFR/EXT/024) * KUNDURU NIRYASA
1.2.2. Uses advised against
No other uses are advised
Emergency telephone
+1-612-221-3999, Ext 221
Icons in SDS
Company Information
company name
GlaxoSmithKline
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H318
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
Physical hazards
Not classified.
Health hazards
Serious eye damage/eye irritation Category 1 Sensitization, skin Category 1
Environmental hazards
Not classified.
Signal word
Danger
Hazard statements
H317 May cause an allergic skin reaction. H318 Causes serious eye damage.
Prevention
P261 Avoid breathing mist/vapours. P272 Contaminated work clothing should not be allowed out of the workplace. P280 Wear eye protection/face protection. P280 Wear protective gloves.
Response
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 Immediately call a POISON CENTRE/doctor/. P321 Specific treatment (see instruction on this label). P333 + P313 If skin irritation or rash occurs: Get medical advice/attention. P362 + P364 Take off contaminated clothing and wash it before reuse.
Storage
Not available.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Other hazards which do not result in classification
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
7 % of the mixture consists of component(s) of unknown acute oral toxicity. 10.85 % of the mixture consists of component(s) of unknown acute dermal toxicity. 5.5 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 7 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 5.5 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment. National/local information Not available
